ORIGINAL ARTICLESpectrofluorimetric determination of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) in pharmaceutical preparation using silver nanoparticles

Add time:08/26/2019    Source:sciencedirect.com

A novel sensitive fluorimetric method was investigated for the assay of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) (FEX) using silver nanoparticles (NPs) as a fluorescence probe. The NPs, which were prepared by chemical reduction of silver nitrate with sodium borohydride (reducing agent) in aqueous solution (without organic stabilizers) were water soluble, stable and had narrow emission band. The addition of drug to NPs solution caused considerable quenching of the emission band of silver NPs, which was likely due to the complexation of the drug to silver NPs. Under the optimum conditions, the quenched fluorescence (FL) intensity was linear with the concentration of FEX in the range of 1 × 10−7 to 2.5 × 10−5 mol L−1 (0.9985) with a detection limit of 1.2 × 10−8 mol L−1. The quenching mechanism of the studied drug on the emission band of silver NPs was explained by Stern–Volmer law. The developed method was applied to FEX determination in a pharmaceutical formulation (allegra tablets) and biological fluids (human serum and urine).

We also recommend Trading Suppliers and Manufacturers of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8). Pls Click Website Link as below: cas 138452-21-8 suppliers

Prev:Original ArticleDevelopment and validation of RP-HPLC method for simultaneous estimation of Montelukast Sodium and FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) in combined dosage form
Next:Chapter 4 - FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8))